{"basic_info": {"ticker": "300630", "exchange": "XSHE", "bloomberg_ticker": "300630 CH Equity", "name": "HAINAN POLY PHARM CO LTD-A", "industry": "Pharmaceuticals", "name_chinese_simplified": "普利制药", "period": "2020", "market_value": 18073876480, "total_income": 401680875, "ccy": "人民币元", "shariah_compliance_summary": "unknown"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 216901503, "business_income_over_total_income": 0.5399846407922707}, {"shariah_compliance": "unknown", "income": 184779370, "business_income_over_total_income": 0.4600153542286523}], "details": [{"business_activity_cn": "抗过敏", "business_activity_en": "anti-allergy", "income": 121194058, "business_income_over_total_income": 0.30171727244917995, "shariah_compliance": "compliant"}, {"business_activity_cn": "其他", "business_activity_en": "other", "income": 98630257, "business_income_over_total_income": 0.24554382132333286, "shariah_compliance": "unknown"}, {"business_activity_cn": "抗生素", "business_activity_en": "Antibiotic-containing", "income": 95707445, "business_income_over_total_income": 0.23826736834309076, "shariah_compliance": "compliant"}, {"business_activity_cn": "非甾体", "business_activity_en": "Nonsteroidal", "income": 44855385, "business_income_over_total_income": 0.11166920755189054, "shariah_compliance": "unknown"}, {"business_activity_cn": "其他业务", "business_activity_en": "Other business", "income": 25957130, "business_income_over_total_income": 0.06462127428894891, "shariah_compliance": "unknown"}, {"business_activity_cn": "合计特别调整", "business_activity_en": "Total special adjustments", "income": 15336598, "business_income_over_total_income": 0.03818105106447998, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 0.04300756061355513, "shariah_compliance": "compliant", "amount_over_market_value": 0.04300756061355513}]}